The forest plot showed that in 33 cancers, RPL4P4 had a significant effect on the survival time according to specific tumor types, and RPL4P4 had a clear correlation with prognosis in patients with gliomas (P < 0.001) (Supplemental Figure 1). Here, RPL4P4 is linked to glioma.